Posts

Showing posts with the label Treatment

Unlocking the Future: Cancer Treatment through Personalized Medicine

Image
Cancer patient treatment has been fundamentally transformed in recent years, as various molecular changes have been identified as the cause of cancer formation and progression. One of the most significant advancements in modern oncology is the shift from an organ-centric philosophy guiding therapy choice to thorough molecular analysis driving a personalized strategy (Gambardella et al., 2020). The term personalized medicine was used ten years ago for the first time, the right drug for the right patient explains best . ‘Personalized medicine' refers to the adaption of medical treatment to each patient's unique traits. It doesn’t mean the development of patient–specific medications or medical devices, but rather the ability to divide individuals into subpopulations that differ in their susceptibility to a given disease or their reaction to a specific treatment (Bates, 2010). Cancer therapy response rates are among the lowest of any major disease, however, now a well-establish...

Lecture on the role of CRISPR CAS-9 in the treatment of HIV

Image
This lecture is presented by our volunteer Sajid Ali Shah, he is from Islamabad, Pakistan, and he is covering The role of CRISPR CAS-9 in the treatment of HIV. for video:  for slides: 

miRNA-Based Therapies: Revolutionizing Cancer Treatment Strategies

Image
Micro RNAs (miRNAs) are small non-coding RNA molecules that play a pivotal role in regulating gene expression post-transcriptionally. Since their discovery in 1993, miRNAs have been identified as key players in various cellular processes, including development, proliferation, differentiation, apoptosis, and stress response [1] . In recent years, miRNAs have gained significant attention in the field of cancer research due to their involvement in tumorigenesis, metastasis, and treatment resistance. This article delves into the intricate relationship between miRNAs and cancer, highlighting their potential as therapeutic targets and exploring the challenges and opportunities of utilizing miRNA-based therapies. miRNAs function by binding to complementary sequences within the 3' untranslated regions (UTRs) of target mRNAs, leading to mRNA degradation or translational repression. This intricate interaction allows miRNAs to fine-tune the expression of numerous genes, ultimately influe...